BPG is committed to discovery and dissemination of knowledge
Articles in Press
8/13/2025 9:49:39 AM | Browse: 245 | Download: 71
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Systematic Reviews |
Article Title |
Beyond corticosteroids: A systematic review of novel therapeutic strategies in severe alcoholic hepatitis and 90-day survival
|
Manuscript Source |
Invited Manuscript |
All Author List |
Marta Quiñones-Calvo, Rubén Alvarado-Jara, Paula García-Renedo, Elena Stallings, Eulalia Grifol-Clar and Conrado M Fernández-Rodríguez |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Hepatology Training Grant from the Spanish Association for The Study of Liver (AEEH-Asociación Española para el Estudio del Hígado) in 2023 |
G28551570 |
|
Corresponding Author |
Marta Quiñones-Calvo, MD, Department of Gastroenterology, Hospital Universitario Fundación Alcorcón, Avenida Budapest 1, Alcorcón 28922, Madrid, Spain. m.quinones.2024@alumnos.urjc.es |
Key Words |
Alcoholic liver disease; Severe alcoholic hepatitis; Corticosteroids; Fecal microbiota transplantation; Granulocyte colony-stimulating factor |
Core Tip |
Severe alcoholic hepatitis (SAH) is associated with high mortality, yet effective mid-term treatments remain limited. This systematic review exclusively examines survival or mortality at 90-day, synthesizing evidence from eight recent studies. While corticosteroids remain the mainstay of current therapy, their survival benefit appears confined to the first 28 days. In contrast, interventions such as Fecal Microbiota Transplantation and granulocyte colony-stimulating factor have emerged as promising approaches for improving 90-day survival, though further validation is needed. This review highlights the urgent need for innovative therapies and high-quality trials to address mid-term survival in SAH, a critical but underexplored therapeutic window. |
Citation |
Quiñones-Calvo M, Alvarado-Jara R, García-Renedo P, Stallings E, Grifol-Clar E, Fernández-Rodríguez CM. Beyond corticosteroids: A systematic review of novel therapeutic strategies in severe alcoholic hepatitis and 90-day survival. World J Gastroenterol 2025; In press |
 |
Received |
|
2025-05-28 09:29 |
 |
Peer-Review Started |
|
2025-05-28 09:29 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-06-11 07:38 |
 |
Revised |
|
2025-06-20 19:02 |
 |
Second Decision |
|
2025-08-11 02:49 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-08-13 09:49 |
 |
Articles in Press |
|
2025-08-13 09:49 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2025-08-19 01:22 |
 |
Typeset the Manuscript |
|
|
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345